Medunik USA

Medunik USA is a specialty pharmaceutical company dedicated to providing access to orphan drugs for patients with rare diseases in the United States. As the US subsidiary of Medunik Canada and a member of Groupe Boivin, the company focuses on the registration, commercialization, and distribution of niche therapies. Its portfolio primarily addresses metabolic and hematologic conditions, featuring products like Pheburane for Urea Cycle Disorders and Siklos for Sickle Cell Disease. Medunik USA operates by partnering with international drug developers to bring essential treatments to underserved patient populations. The company provides comprehensive medical and patient support services to ensure the successful adoption of its orphan drug therapies. Headquartered in Pennsylvania, Medunik USA continues to expand its footprint in the American rare disease market.